R-S-S offers strategic consultancy to help design protocols for the dual objective of drug licensing and HTA (Health Technology Assessment) & Market Access at each and every step of the drug development process. 

Our services include study design, protocol support, statistical analysis plan, report/medical writing, statistical programming, regulatory expertise, dossier preparation, responses to Payer questions and providing technical solutions such as Systematic Literature Review (SLR) slutions using Artificial Intelligence and Machine Learning algorithms. (less)